Difference between revisions of "Orange Book Companion"
Jump to navigation
Jump to search
(→Info) |
(→Info) |
||
Line 10: | Line 10: | ||
*[http://www.orangebookcompanion.com/description.htm Why Subscribe to The Orange Book Companion] | *[http://www.orangebookcompanion.com/description.htm Why Subscribe to The Orange Book Companion] | ||
*[http://www.orangebookcompanion.com/Bruce_Pokras_Conference_Presentations.htm Bruce Pokras' Presentation History] | *[http://www.orangebookcompanion.com/Bruce_Pokras_Conference_Presentations.htm Bruce Pokras' Presentation History] | ||
− | *[http://www.orangebookinsights.com/ Bruce's | + | *[http://www.orangebookinsights.com/ Bruce's Insights: A Comment Blog] |
== See Also == | == See Also == |
Revision as of 18:05, 30 December 2018
http://www.orangebookcompanion.com
Free and paid information about patents covering FDA-approved drugs
Enchanced FDA "Orange Book" patent and exclusivity information for FDA-approved drugs created by a Philly native.
- Drug Patent Expirations, Patent Titles, Claim Types, Drug Classes, Hyperlinks to the patents and FDA Info, and much more.
- Historical Orange Book patent and exclusivity info back to the dawn of the Hatch-Waxman Act in 1984.
Info
- Why Subscribe to The Orange Book Companion
- Bruce Pokras' Presentation History
- Bruce's Insights: A Comment Blog